RESEARCHER PROFILE
Assoc Professor Cedric Bardy, SAHMRI (2023)
Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells
South Australian Health and Medical Research Institute (SAHMRI) &
Professor, Flinders University
Adelaide, South Australia
Filmed November 2023
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
In particular, Cedric is the inventor of BrainPhys; a neuronal medium broadly used to culture human neurons in vitro, commercialised by STEMCELL Technologies.
The ability to grow human brain cells in a petri dish opens up new possibilities for research and discovery in neuroscience.
The BrainPhys medium allows human brain cells to function as they would in the adult human brain, revolutionizing research in labs across the world.
Cedric Bardy’s research enables researchers to study human brain disorders in a more physiological context, potentially leading to new treatments for brain cancer, Parkinson’s disease, and Sanfilippo Syndrome.
Cedric Bardy’s international journey from France to Canada to Australia and then to the United States showcases the global nature of scientific research and collaboration.
The passion for neuroscience stems from the fact that everything we care about as humans is influenced by brain activity.
Cedric Bardy is passionate about finding ways to treat the brain when things go wrong, showing a deep commitment to neurological research.
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
-
Role of metabolic dysfunction in advanced prostate cancer
Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.
-
Genetic disease research imitating function and architecture of organs
Professor Wolvetang was among the first to bring the first human embryonic stem cells to Queensland, with his Wolvetang Group at the AIBN now renowned for its work with organoids: growing them, studying them, and using them to try and understand diseases and human development.
Using cutting edge technology, Professor Wolvetang designs and grows organoids both for their own work and for labs across the country, coaxing pluripotent stem cells or tissue samples into 3D structures that mimic the function and architecture of real brains, livers, kidneys, spinal cords, and intestines.
